Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.

Next-generation sequencing (NGS)-based profiling of both urinary tumor DNA (utDNA) and circulating tumor DNA (ctDNA) shows promise for noninvasive detection and surveillance of urothelial bladder cancer (UBC).